COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Comparison of Osteocentral Versus Locoregional Anesthesia in Case of Mandibular Molar Pulpitis (COQ)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03802305
Recruitment Status : Recruiting
First Posted : January 14, 2019
Last Update Posted : April 1, 2019
Information provided by (Responsible Party):
Nantes University Hospital

Brief Summary:

The irreversible acute pulpitis is the most common emergency at the hospital during dental consultation. Pulpitis are characterized by intense and spontaneous oro-facial pains. In case of mandibular molar, the emergency treatment consists in realizing a pulpotomy (eviction of cameral pulp) under locoregional anesthesia called inferior alveolar nerve block (IANB). The latter represents a real challenge, since inflammation may decrease its action. To mitigate this deficiency and the drawbacks of the IANB (onset and duration of the anesthesia, bites risk reported with IANB) other anesthesias are proposed. In particular the computerized intraosseous technique anesthesia of which the Quicksleeper™ system is a part. However, according to the observers, a mild to severe tachycardia have been reported.

Very few valid clinical trials exists on the subject, most being realized with systems of intraosseous anesthesia other than Quicksleeper™. Therefore, the aim of this study is first to analyze the variations of the cardiovascular parameters into two groups of anesthesia: locoregional anesthesia and Quicksleeper ™ system; and then, to compare the efficiency, side effects, operating consequences of both techniques. This study should provide better data about potential risk with computerized intraosseous technique such has Quicksleeper ™ system in healthy or cardiovascular risk patient.

Condition or disease Intervention/treatment Phase
Endodontic Inflammation Device: computerized intraosseous technique (Quicksleeper™) Device: loco-regional anesthesia (IANB technique) Not Applicable

Detailed Description:

When the patient arrive in the dental care center, an initial assessment is made to get the diagnosis of irreversible pulpitis:

  1. Anamnesis:

    acute and spontaneous oro-facial pain, pulsatile severe intensity, which could irradiate toward the ear and/or jaw, exacerbated by cold or hot.

  2. Clinical exams: positive vitality tests (electric test and cold pressor test)
  3. Further examination (radiography)

The inclusion and exclusion criteria will be checked and the informed consent of the patient will be taken. The patient is then randomized in one of the group (experimental or control). He will fill a questionnaire (Corah's scale) for evaluating his state of anxiety during care. A monitoring of cardiac parameters is made during the care at defined moment.

The patient evaluates his pain himself with the VAS (Visual Analog Score), before the intervention. The anesthesia is carried out by only one experimenter, with the Quickslepper™ handpiece but different specific needles.

Each patient receive 1.8 mL of 4% articaine 1:100 000 on a period of 2 minutes.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 72 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: Number of Arms: 2 Masking: Simple Blinded, Masked Roles: Subject Allocation: Randomized Study Endpoint Classification: Interventional Research with Minimal Risk and Constraints, Safety/Efficacy Enrollment: subjects (anticipated)
Masking: Single (Participant)
Primary Purpose: Treatment
Official Title: Comparison of the Variations of the Cardiovascular Parameters and the Efficiency of the Osteocentral Anesthesia (Quicksleeper™) and the Locoregional Anesthesia in the Case of Mandibular Pulpitis
Actual Study Start Date : March 1, 2019
Estimated Primary Completion Date : March 2020
Estimated Study Completion Date : March 2020

Arm Intervention/treatment
Experimental: Computerized intraosseous technique (Quicksleeper™)
patients will receive the anesthetic solution with computerized intraosseous technique anesthesia near the tooth roots involved.
Device: computerized intraosseous technique (Quicksleeper™)

The anesthetic solution is administered with a specific equipment allowing the injection step by step:

  • anesthesia of the interdental papilla,
  • positioning of the needle and perforating of the interdental space,
  • Injection of the solution. All of these steps are based on an adjustment of the different part of this equipment.

Active Comparator: loco-regional anesthesia (IANB technique)
patients will receive the anesthetic solution with the loco-regional anesthesia technique: near the place where the nerve goes into the jaw, based on osteo muscular markers.
Device: loco-regional anesthesia (IANB technique)
The anesthetic solution is delivered by a needle near to the inferior alveolar nerve before it enters the mandibular foramen.

Primary Outcome Measures :
  1. time required (in minutes) to re-obtain the baseline cardiovascular parameters like reported before injection: expected event. [ Time Frame: at day 0, from T0 minute to T14 minutes ]
    • 3 successive values of heart rate similar to those registered before injection.
    • 3 successive values of blood pressure (diastolic and systolic) similar to those registered before injection.

Secondary Outcome Measures :
  1. Compare the pain of the patient between the two anesthetic techniques [ Time Frame: 3 days ]
    Scores measured with Visual Analog Score( Heft-Parker's pain assessment) (minimum score : no pain ; maximal score : maximum pain unimaginable)

  2. Compare the possible postoperative course between the 2 anesthetic techniques [ Time Frame: 3 days ]
    The postoperative course will be evaluated using a post-operative table to be completed by the patient at Day + 1, Day + 2 and Day + 3. Collection of information by phone call to the patient. The presence or absence of the following item is measured : pain after waking up, swelling, hematoma, seepage, higher tooth sensation, bite, possibility of feeding, mouth opening limitation.

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • real irreversible pulpitis of a mandibular molar in dental emergency consultation at the Nantes hospital
  • Healthy patient without medical history (ASA 1), without treatment for heart rate distress (anti arrhythmic, beta-blocking drug)
  • Major and covered by the social security
  • Informed consent

Exclusion Criteria:

  • ASA > 1
  • Pregnant and breastfeeding women
  • Minors
  • Adults under guardianships
  • Adults deprived of freedom
  • Impossibility to obtain for informed consent
  • Allergy to anesthetic components
  • Contraindication of vasoconstrictor
  • Angle closure glaucoma

    • Pheochromocytomas
    • Bisphosphonate IV
    • Irradiated patient (upper respiratory and gastrointestinal tract cancer)
    • Contraindication with Mono-amino oxidase inhibitors
  • Acute apical periodontitis
  • Pulpitis on wisdom teeth
  • Vital teeth with fixed prosthesis
  • Active periodontal disease
  • Local anatomic difficulty
  • No reference tooth for vitality dental test

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT03802305

Layout table for location contacts
Contact: Alexis GAUDIN +33 2 40 41 29 13
Contact: Tony PRUD'HOMME +33 6 77 48 96 48

Layout table for location information
Nantes Universitary Hospital Recruiting
Nantes, Loire-Atlantique, France, 44093
Contact: Alexis GAUDIN         
Principal Investigator: Alexis GAUDIN         
Sponsors and Collaborators
Nantes University Hospital
Layout table for additonal information
Responsible Party: Nantes University Hospital Identifier: NCT03802305    
Other Study ID Numbers: RC18_0268
First Posted: January 14, 2019    Key Record Dates
Last Update Posted: April 1, 2019
Last Verified: March 2019

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Pathologic Processes
Dental Pulp Diseases
Tooth Diseases
Stomatognathic Diseases
Central Nervous System Depressants
Physiological Effects of Drugs